Cutting-Edge Basic Research Awards (CEBRA) (R21)

Funding Agency:
National Institutes of Health

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA's current portfolio. The proposed research should: (1) test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking; and/or (2) develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research. 

Deadlines:

  • Letter of Intent: 30 days prior to the application due date
  • Application Due Date(s): August 20, 2018; December 20, 2018; August 20, 2019; December 20, 2019; August 20, 2020; and December 18, 2020
  • AIDS Application Due Date(s): August 20, 2018; December 20, 2018; August 20, 2019; December 20, 2019; August 20, 2020; and December 18, 2020

PAR-18-437 Expiration Date: December 19, 2020

Agency Website

Amount

$275,000

Amount Description

 The combined budget for direct costs for the two year project period may not exceed $275,000. No more than $150,000 in direct costs may be requested in any single year.

 The maximum project period is 2 years.      

    Funding Type

    Award

    Eligibility

    Faculty

    Category

    Medical
    Medical - Clinical Science
    Medical - Translational

    External Deadline

    December 20, 2019